South Texas Money Management’s Novartis NVS Stock Holding History

South Texas Money Management’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$919K	Buy	10,581 +4,049	+62%	+$364K	0.04%	161
2019 Q2	$596K	Sell	6,532 -758	-10%	-$64.2K	0.03%	135
2019 Q1	$628K	Sell	7,290 -1,717	-19%	-$138K	0.03%	132
2018 Q4	$693K	Sell	9,007 -120	-1%	-$9.34K	0.03%	130
2018 Q3	$705K	Sell	9,127 -2,804	-24%	-$207K	0.03%	144
2018 Q2	$808K	Sell	11,931 -232,038	-95%	-$16M	0.04%	125
2018 Q1	$17.7M	Buy	243,969 +238,427	+4,302%	+$18.2M	0.81%	42
2017 Q4	$417K	Hold	5,542	–	–	0.02%	152
2017 Q3	$426K	Sell	5,542 -263	-5%	-$19.9K	0.02%	150
2017 Q2	$434K	Buy	5,805 +263	+5%	+$18.6K	0.02%	147
2017 Q1	$369K	Sell	5,542 -1,666	-23%	-$111K	0.02%	166
2016 Q4	$470K	Buy	7,208 +1,666	+30%	+$108K	0.02%	142
2016 Q3	$392K	Sell	5,542 -385	-6%	-$28.1K	0.02%	145
2016 Q2	$438K	Buy	5,927 +385	+7%	+$26.6K	0.02%	134
2016 Q1	$360K	Sell	5,542 -1,122	-17%	-$76.3K	0.02%	156
2015 Q4	$514K	Sell	6,664 -15	-0.2%	-$1.19K	0.03%	131
2015 Q3	$550K	Buy	6,679 +183	+3%	+$16.3K	0.03%	122
2015 Q2	$572K	Sell	6,496 -236	-4%	-$21.6K	0.03%	122
2015 Q1	$595K	Buy	6,732 +712	+12%	+$63.2K	0.03%	117
2014 Q4	$500K	Hold	6,020	–	–	0.03%	123
2014 Q3	$508K	Sell	6,020 -246	-4%	-$19.9K	0.03%	117
2014 Q2	$508K	Sell	6,266 -44	-0.7%	-$3.46K	0.03%	119
2014 Q1	$481K	Buy	6,310 +414	+7%	+$30.2K	0.03%	121
2013 Q4	$425K	Sell	5,896 -230	-4%	-$16K	0.03%	124
2013 Q3	$421K	Sell	6,126 -390	-6%	-$25.8K	0.03%	112
2013 Q2	$413K	Buy	+6,516	New	+$424K	0.03%	115

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Mawer Investment Management Calgary, Alberta, Canada $14.7B AUM 12.5% 1-Year Est. Return

South Texas Money Management's NVS Position: Q3 2019 in Review

South Texas Money Management increased its Novartis (NVS) stake by 62% in Q3 2019, buying an estimated $364K and bringing the position to 10,581 shares worth $919K. The position accounts for 0.04% of the portfolio, ranked #161.

South Texas Money Management first reported a position in NVS in Q2 2013 and has held it in 26 quarters since. The position peaked at $17.7M in Q1 2018. 1,091 funds tracked by Wall St. Rank hold NVS as of Q3 2019.

South Texas Money Management held 10,581 shares of Novartis worth $919K as of Q3 2019.
South Texas Money Management bought 4,049 Novartis shares in Q3 2019, an estimated $364K.
Novartis made up 0.04% of South Texas Money Management's portfolio in Q3 2019, its #161 holding.
South Texas Money Management first reported a position in Novartis in Q2 2013 and has held it in 26 quarters since.
South Texas Money Management's Novartis position peaked at $17.7M in Q1 2018.
1,091 funds tracked by Wall St. Rank held Novartis as of Q3 2019.

Based on South Texas Money Management's 13F filing for Q3 2019, filed 13 Nov 2019.